delamanid
A novel nitroimidazole antibiotic for treating Mycobacterium tuberculosis infection. Delamanid inhibits bacterial cell wall growth by mycolic acid synthesis disruption and is particularly effective in combination therapies against multidrug-resistant tuberculosis.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
nitroimidazole antibioticARO:3004115
- nitroimidazole antibiotic
ARO:3004115
Chemical structure
| Molecular formula | C25H25F3N4O6 |
|---|---|
| Charge | 0 |
| Average mass | 534.491 Da |
| Monoisotopic mass | 534.17262 Da |
| Source | ChEBI |
| InChIKey | XDAOLTSRNUSPPH-XMMPIXPASA-N |
C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1
InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1
Also called
- deltyba
Cross-references
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3004490 |
delamanid | antibioticmech:aro-2882d6317b |
2026-08-30 |
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Mycobacterium tuberculosis complex | INTERMEDIATE | — | — | CRyPTIC DST; CLIRES2020; solid media | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.03 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
581 source isolates 581 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.03 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
122 source isolates 122 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.03 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
101 source isolates 101 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.06 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
307 source isolates 307 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.06 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
66 source isolates 66 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.06 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
52 source isolates 52 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.12 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
128 source isolates 128 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.12 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
27 source isolates 27 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.12 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
9 source isolates 9 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.25 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
16 source isolates 16 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.25 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
9 source isolates 9 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.25 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
2 source isolates 2 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.5 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
11 source isolates 11 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.5 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
12 source isolates 12 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.5 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
2 source isolates 2 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 1.0 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
6 source isolates 6 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 1.0 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
9 source isolates 9 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 1.0 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
4 source isolates 4 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | <=0.015 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
3890 source isolates 3890 measurements |
EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 5
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Mycobacterium tuberculosis ddn mutation conferring resistance to nitroimidazole antibiotics | ARO:3007661 | — | ||
| Mycobacterium tuberculosis fbiA with mutation conferring resistance to delamanid | ARO:3009339 | — | ||
| Mycobacterium tuberculosis fbiB with mutation conferring resistance to delamanid | ARO:3009340 | — | ||
| Mycobacterium tuberculosis fbiC with mutation conferring resistance to delamanid | ARO:3009341 | — | ||
| Mycobacterium tuberculosis fgd1 with mutation conferring resistance to delamanid | ARO:3007849 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_spectrum (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_membership_collections (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.